Hired and Retired: Pharma C-suites see new faces 15-Feb-2019 By Maggie Lynch While last month saw many pharma executives leaving their positions to head towards smaller biotech companies, this month saw members of the industry climbing the ladder from various different starting points.
Clinigen pays Novartis $210m for US rights to Proleukin 13-Feb-2019 By Ben Hargreaves Clinigen has agreed to acquire the global rights for Proleukin, after Novartis accepted a $210m fee in exchange for the asset.
